Resources

Welcome to our searchable resource and literature collection on safer supply and related topics.

Found a broken link? Links do move around, so if you find one here that's broken, please let us know through the Contact form.

Would legalizing illicit opioids reduce overdose fatalities? Implications from a natural experiment

Examines whether the provision of regulated and quality-controlled heroin to users in specified doses would reduce heroin overdose rates

Commentary | 2014

Overdose, Policy/Regulatory, Safer supply

"The Times They Are a-Changin'": Addressing Common Misconceptions About the Role of Safe Supply in North America's Overdose Crisis

Response to responses on Bonn et al "Addressing the Syndemic…"

Letter | 2021

Policy/Regulatory, Safer supply, Advocacy, Illegal drugs

A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia

To examine characteristics of first-time methadone and buprenorphine clients and factors associated with risk of leaving first treatment in New South Wales (NSW), Australia.

Original research | 2015

Harm reduction, About prescribers, Outcomes, Crime, Legal system/law enforcement, Substitution/OAT

Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply

Commentary | 2020

Safer supply, Decriminalization/legalization, Advocacy, Housing

Assessment tools measuring health-related empowerment in psychosocially vulnerable populations: a systematic review

This systematic review aims to describe and summarise psychometric properties, feasibility and clinical utility of the available tools for measuring empowerment in psychosocially vulnerable population

Lit review | 2021

Equity, Peer/PWLLE program involvement, Social benefits

Canadian Pain Task Force Report: March 2021

Report | 2021

Overdose, Harm reduction, Policy/Regulatory, Equity, Advocacy, About prescribers, About PWUD, Legal system/law enforcement, Illegal drugs, Youth, Chronic pain, Workplace, 2SLGBTQI+, Indigenous, Sex/Gender , Mental health

Caring for hospital patients who inject drugs

Slide deck | 2019

Clinical guidance, Harm reduction, About prescribers, Illegal drugs, Hospitals

Caring for people who inject drugs when they are admitted to hospital

Commentary | 2021

Withdrawal, Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Stigma, Hospitals

Decisions Around Prescribing Opioids for “Safe Supply”

Newsletter | 2019

Hesitancy of prescribers , Safer supply, About prescribers, Injecting drugs

Decriminalizing drug possession in Canada: Recent developments

Slide deck | 2021

Policy/Regulatory, Decriminalization/legalization, Advocacy, About PWUD

Expertise of people who use drugs must be central to design of safe supply

Commentary | 2020

Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Advocacy, About PWUD, Illegal drugs, Peer/PWLLE program involvement

National Injectable Opioid Agonist Treatment Guideline

The clinical guideline was developed to provide key clinical recommendations, as well as clinical guidance on the provision of iOAT.

Guidelines | 2019

Clinical guidance, Policy/Regulatory, Safer supply, About prescribers, Illegal drugs, Stimulants, Transitions in care/treatment, Injecting drugs

Problems with hydromorphone prescribing as a response to the opioid crisis

Various practical and theoretical arguments against take-home opioid maintenance programs

Letter | 2020

Policy/Regulatory, Safer supply

Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015–2018: a repeated cross-sectional analysis

To describe opioid agonist treatment prescribing rates in provincial prisons and compare with community prescribing rates.

Original research | 2021

About prescribers, Legal system/law enforcement, Substitution/OAT

RE: Problems with hydromorphone prescribing as a response to the opioid crisis

Response to Tyndall

Commentary | 2019

Harm reduction, Policy/Regulatory, About prescribers, Injecting drugs

Regarding Issues of the Safe Supply Options for Opioids in the “Risk Mitigation in the Context of Dual Public Health Emergencies” Guideline

Inform PWUD about the costs and benefits of the Safe Supply options

Commentary | 2020

Policy/Regulatory, Safer supply, Advocacy, About PWUD

Research 101: A Manifesto for Ethical Research in the Downtown Eastside

This manifesto builds on, and complements, the work of many other DTES organizations to empower themselves in setting up more equitable and ethical partnerships with researchers.

Report | 2019

About PWUD, Peer/PWLLE program involvement

Safe Supply Concept Document

To outline the concept of safe supply including its role in drug policy

Commentary | 2019

Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Equity, Advocacy, About PWUD, Stimulants

Securing Safe Supply During COVID-19 and Beyond: Scoping Review and Knowledge Mobilization

Scoping review to identify key concepts, strategies and gaps in evidence with respect to the provision of safe supply during pandemics and other emergencies.

Scoping review | 2020

Policy/Regulatory, Safer supply, About prescribers, About PWUD, Barriers and enablers